The Triad: Erectile Dysfunction - Endothelial Dysfunction - Cardiovascular Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|14|35|3700-3714

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.14, Iss.35, 2008-12, pp. : 3700-3714

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral agents are successful in the treatment of erectile dysfunction in patients with cardiovascular disease

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 21, Iss. 6, 2005-06 ,pp. : 16-19

Adis International

Access to resources Recommend Favorite

Treatment of Erectile Dysfunction in Patients with Cardiovascular Disease: Guide to Drug Selection

By Graham Jackson  

Drugs, Vol. 64, Iss. 14, 2004-01 ,pp. : 1533-1545

Adis International

Access to resources Recommend Favorite

Aetiology and Management of Male Erectile Dysfunction and Female Sexual Dysfunction in Patients with Cardiovascular Disease

By Archer Stephen L.  

Drugs & Aging, Vol. 22, Iss. 10, 2005-01 ,pp. : 823-844

Adis International

Access to resources Recommend Favorite

Oxidative Stress and Endothelial Dysfunction in Cardiovascular Disease: Mitochondria-Targeted Therapeutics

By  

Current Medicinal Chemistry, Vol. 17, Iss. 32, 2010-11 ,pp. : 3827-3841

Bentham Science Publishers

Access to resources Recommend Favorite

Endothelial Effects of Drugs Designed to Treat Erectile Dysfunction

By  

Current Pharmaceutical Design, Vol. 14, Iss. 35, 2008-12 ,pp. : 3768-3778

Bentham Science Publishers

Access to resources Recommend Favorite